RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Bright Minds Biosciences Stock

Bright Minds Biosciences Liabilities 2024

Bright Minds Biosciences Liabilities

0 CAD

Ticker

DRUG.CN

ISIN

CA10919W4056

In 2024, Bright Minds Biosciences's total liabilities amounted to 0 CAD, a 0% difference from the 0 CAD total liabilities in the previous year.

Bright Minds Biosciences Aktienanalyse

What does Bright Minds Biosciences do?

Bright Minds Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Bright Minds Biosciences's Liabilities

Bright Minds Biosciences's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Bright Minds Biosciences's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Bright Minds Biosciences's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Bright Minds Biosciences's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Bright Minds Biosciences’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Bright Minds Biosciences stock

What is the level of liabilities of Bright Minds Biosciences this year?

Bright Minds Biosciences has a debt balance of 0 CAD this year.

What were the liabilities of Bright Minds Biosciences compared to the previous year?

The liabilities of Bright Minds Biosciences have increased by 0% dropped compared to the previous year.

What are the consequences of high debt for investors of Bright Minds Biosciences?

High liabilities can pose a risk for investors of Bright Minds Biosciences, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Bright Minds Biosciences?

Low liabilities mean that Bright Minds Biosciences has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Bright Minds Biosciences affect the company?

An increase in liabilities of Bright Minds Biosciences can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Bright Minds Biosciences affect the company?

A decrease in the liabilities of Bright Minds Biosciences can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Bright Minds Biosciences?

Some factors that can influence the liabilities of Bright Minds Biosciences include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Bright Minds Biosciences so important for investors?

The liabilities of Bright Minds Biosciences are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Bright Minds Biosciences take to modify the liabilities?

To change its liabilities, Bright Minds Biosciences can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Bright Minds Biosciences pay?

Over the past 12 months, Bright Minds Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Bright Minds Biosciences is expected to pay a dividend of 0 CAD.

What is the dividend yield of Bright Minds Biosciences?

The current dividend yield of Bright Minds Biosciences is .

When does Bright Minds Biosciences pay dividends?

Bright Minds Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Bright Minds Biosciences?

Bright Minds Biosciences paid dividends every year for the past 0 years.

What is the dividend of Bright Minds Biosciences?

For the upcoming 12 months, dividends amounting to 0 CAD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Bright Minds Biosciences located?

Bright Minds Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Bright Minds Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Bright Minds Biosciences from 11/25/2024 amounting to 0 CAD, you needed to have the stock in your portfolio before the ex-date on 11/25/2024.

When did Bright Minds Biosciences pay the last dividend?

The last dividend was paid out on 11/25/2024.

What was the dividend of Bright Minds Biosciences in the year 2023?

In the year 2023, Bright Minds Biosciences distributed 0 CAD as dividends.

In which currency does Bright Minds Biosciences pay out the dividend?

The dividends of Bright Minds Biosciences are distributed in CAD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Bright Minds Biosciences

Our stock analysis for Bright Minds Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Bright Minds Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.